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T lymphocytes expressing the T-cell yS receptor have been shown to express preferentially the T-cell receptor V9 
y(TRGV9) gene, in association with the T-cell receptor V2 S(TRDV2) gene. In this paper, we report that the promoter 
regions of the TRDM and TRGV9 genes, which are preferentially expressed early in T-cell differentiation, display short 
direct repeats but no TATA box, in contrast to the Vy genes belonging to subgroup I. The TCCTCAGT octanucleotide 
found 100 pb upstream of the ATG of the HD-Mar Va transcript, a TcR Va gene without a TATA box, is observed 
upstream of TRDV2 but not TRGV9. Of interest is the presence of a characteristic decanucleotide AGGTGGT(T)GAG 
in the promoter regions of both the TRDV2 and TRGV9 genes. 
Promoter region; Receptor, y T-cell; Receptor, 6 T-cell; Gene, variable; Tran~~ption; (Human) 
1. INTRODUCTION 
In human peripheral blood, about 3-5% of the 
circulating cells express the T-cell y/6 receptor. The 
organization of the genes encoding the y, 6 chains 
and that of the corresponding loci have recently 
been elucidated. The human T-cell receptor y 
(TRG) [I] locus which has been mapped on 
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chromosome 7 [2] at band 7~15 [3], comprises two 
constant region genes (TRGC) [4,5] and 14 variable 
(TRGV) y genes, belonging to four subgroups 
[6-81 (reviews [9-l 11). Nine of them, five func- 
tional (V2, V3, V4, V5 and V8) and four 
pseudogenes (Vl, V5P, V6, V7), belong to 
subgroup I, whereas subgroups II, III and IV each 
consist of a single gene, designated V9, VlO and 
VI 1, respectively [6-81. Two pseudogenes, VA and 
VB, located upstream of V9 and Vl 1, respectively, 
belong to none of these subgroups [7,8]. Three y 
joining segments, JPl [12-141, JP [16] and Jl [4], 
have been identified upstream of TRGCI , and two 
others, JP2 [12-14] and 52 [4] upstream of 
TRGCZ. With its 14 variable genes spanning 100 
kb, the two constant region genes and 5 joining 
segments covering less than 40 kb [15] and only 16 
kb separating the most 3’ V gene (VII) from the 
most 5’ J (JPl) segment, the human TRG locus 
spans 160 kb of genomic DNA [16] (fig.lA). 
The human T-cell receptor 6 (TRD) locus is 
embedded in the T-cell receptor a! locus between 
the VEX and Ja! segments at 85 kb in 5’ from the Cal 
gene. It comprises a unique constant region gene 
Published by Elsevier Science Publishers B. V. (‘Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 185 
FEBS LETTERS Volume 256, number 1,2 
A 
Human TRG locus 
3lL 
October 1989 
. 100kb +-18kb+ - 40kb -I 
B 
Human TRD locus skb - 
Fig. 1. (A) Organization of the human T cell receptor y TRG locus (from [16]). The human TRG locus comprises 14 TRGV genes, eight 
of which are functional and belong to four different subgroups [4, 6-81. The functional V genes and the pseudogenes ( ee text) are 
represented by black and grey rectangles, respectively. The two TRGC genes [1,4,5] are shown with the associated TRGJ segments Jl, 
52 [4], JP [6], JPl and JP2 [12-141. In the TRGCZ gene, the dotted box represents the exon 2T characteristic of the allele C2(3X) [15]. 
(B) Schematic representation of the human T-cell receptor 6 TRD locus [ 17-291. The human TRD locus comprises a unique constant 
region gene TRDC preceded by the three TRDJ segments Jl, 52 and 53 and three D segments Dl, D2 and D3 [17-271. Vl corresponds 
to the variable gene of the O-240/38 [17] and PEER [18] cDNA clones and V2 to the Xl3 [28] and LB117 [27] cDNA clones. V3 has 
recently been identified downstream of TRDC [26,27]. 
C6 (TRDC) preceded by at least three joining gene 
segments (TRDJ) and three diversity segments 
[17-271. The number of the variable 6 genes 
(TRDV) seems limited. So far three of them Vl 
[17,18], V2 [27,28] and V3 [26,27] have been iden- 
tified, the gene V3 lying in an inverted orientation, 
3’ of the C6 gene (fig.lB). 
The majority of the human TcR y/6+ cir- 
culating cells express a receptor with a limited y 
and 6 chain combinatorial diversity that derived 
from the preferential TRGV9-JP and TRDV2-D- 
J 1 rearrangement, respectively [30-321. Here, we 
report the sequence of the promoter region of the 
TRDV2 gene, that of the TRGV9 gene, as well as 
those of the V y genes belonging to subgroup I. We 
show that the promoter region of TRDV2 and 
TRGV9, in contrast to the V y genes belonging to 
subgroup I, do not include the classical ‘TATA’ 
and ‘CAAT’ boxes but instead display short 
186 
repeats in tandem, suggesting that the transcription 
of both TRDV2 and TRGV9 genes is initiated from 
a non-TATA promoter. A characteristic 
decanucleotide AGGTGGT(T)GAG is found in the 
promoter regions of both the TRDV2 and TRGV9 
genes. This is of interest, since both TRDVZ and 
TRGV9 genes appear to be expressed early in T-cell 
differentiation [28,32]. 
2. MATERIALS AND METHODS 
2.1. Isolation of the 5 ‘-TRDM nucleotide sequence 
A 600 bp fragment located upstream of the ATG codon of the 
TRDVZ gene has been sequenced. This fragment was isolated 
from the XLY67V62 genomic clone, containing the TRDVZ gene 
]331. 
2.2. Isolation of the 5’-TRGVI, -M, -V3, -V4, -V8 and -V9 
nucleotide sequences 
The 5’ region of the Vl, V2, V3, V4 and V8 genes (Vy 1 
subgroup genes) have been sequenced from the Sac1 site located 
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236 bp upstream of the ATG codon [6]. The corresponding 
subclones were isolated respectively from XFI and XF6 (Vl), 
XSH4 (VZ), XSl and XSH4 (V3), XS13 (V4), XK20 (VS). These 
clones have previously been described 161. A 2.7 kb HindID- 
Sac1 fragment containing the TRGV9 gene was isolated from 
the X K20 clone [4]. 
2.3. Subcloning and sequencing strategies 
Appropriate subclones were made in pUC vector [34]. 
Nucleotide sequence analysis was carried out by dideoxy chain- 
te~ination procedures [35] in Ml3 vectors f36], via exonuclease 
III-nuclease Si methods 1371 or directed sequencing using 
known restriction enzyme sites. 
3. RESULTS 
The TRDV2 gene is preferentially expressed with 
the TRGVP gene in T lymphoc~es expressing the 
y/s receptor (28, 31, 321. It was therefore of in- 
terest to analyse the promoter regions of both 
genes. The sequences of the region upstream of the 
ATG of TRDV2 isolated from XLY67V62 [33] and 
that of TRGV9 isolated from xI(20 [4, 7, 81 are 
shown in figs 2 and 3, respectively. The 5 ’ un- 
translated regions of TRDV2 and TRGV9 have 
been characterized to identify sequences which may 
have significance in the initiation of transcription. 
Although two A-T-rich regions are noted 500 and 
580 bp, respectively, upstream of the initiation 
methionine codon ATG of TRGVP, it seems 
unlikely that they represent he conserved TATA 
box which has for consensus the conserved 
TATAAAA sequence [38]. Indeed, a 500 bp un- 
translated sequence would be very unusual, since a 
compilation of eukaryotic cellular mRNAs shows 
that 95% of them have 5’ untranslated regions less 
than 160 bp long 1391. We therefore looked for 
other sequences in the region more proximal to the 
VP gene and in the V2 promoter region. No con- 
10 20 30 40 50 60 
CTGCAGAATA AAGATCAGGA B CACATmGGA AGAcCATGTr TCATTGGAlT -537 
70 80 90 100 110 120 
GCTCTTTAAC ACATGGGTAA ATCACCCTTA TC!CAAC!l-lTG CCTAGAGGGA GTTI’GCAGTG -477 
130 140 150 160 170 180 
AACACAAGAA TCATTACAAG ATCTTCA GTG TlTGTGCACA TGCTATTGAT CTCGTGATTT -417 
5 * * 
190 200 210 220 230 
4 
240 
GGTGGl%XT Tl!GAl?l’ACAG CTGTAAATGG CAATAA’ITCT TGTTGGTATG AAGTATGAAC -357 
250 260 270 280 290 300 
A!XACCACAT AGTGTGTAAC ATGTACATCT AAGGTGAAA C TGGAAGAACA ATATGAAATI’ -297 
- 310 320 330 340 5 350 360 
TAACGTCi’AG GGAAGGAAGC AGAAAGCGTG TCACCAAl’TA AATAAGCTGG GTl’AA7’Ci’GC -237 
370 380 390 400 410 4 420 
TGTGAG!gTGG CGTAAGl-l’AC CTGAACGGTA CTATl%7!CT TGAAGGTGGC ACTGTCATCC -177 
_) 
430 440 450 460 470 480 
CAlTAGCAGG CAGCAGGCCC TGCGAGCf=KZ CTGTGATCAG CTAGA!ri’TCT CHXGGAATG -If7 
AAACAS ;TAz: TGA@;_k+~ FL FTG; - 57 
550 560 580 590 
-GGCAGAGC TGUXCEAG TGAGCCATGC CAGAGGAGGG ACCAGGCAGA m 
,600 
-- M 
Fig.2. Nucleotide sequence of the 5’ untranslated region of the human TRDVZ gene. M indicates the initiation methionine codon 
(ATG). Pairs of direct repeats are shown by underlining arrows and are numbered. Nucleotide + 1 denotes the A of the ATG encoding 
the initiation methionine codon of the TRDVZ gene and nucleotides preceding this codon are indicated by negative numbers on the right- 
hand side of the sequence. The TCCTCAGT octanucleotide, also found upstream of the HD-Mar Va! transcript, is shown by the dashed 
box. Except for the presence of an additional nucleotide, the boxed sequence is found to be identical to that in the promoter region 
of TRGV9 (see fig.3). 
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10 20 30 40 50 60 
AAGCATGGM ATGTGGAA CA GAGCAGGTTT TAAGGGATGC AtlXWXGA r2A WGTTTGTA -597 
70 80 90 100 110 120 
AAAATACCPT GGGACGGATT AAATGTCTTG GCTTAGAGAA AGAACAACAG ACAATAGGAA -537 
130 140 150 160 170 180 
ACTGTCAlTG AGGAGAAGCC GGATTCAGGA GATGTACATT ATTCAGGTAG CTGAGGGAGG -477 
190 200 210 220 230 240 
GGACAGGAAC CTGAATCTCA CAGAGCAACA ACTGGGATGG AGGGCCCAGC CTCATGAAGG -417 
250 260 270 280 290 300 
TGACCAGAAG GAC!GC!GGTGG T CAGGCTGT GTGGGTAGCT GAGCAGAGCT AAGCGCFEA -357 
310 320 330 340 350 360 
CGGACCAACA TCTCTCCAGC TGGlTGAAGA CAAGc?lXXU GAAGACAATG CTGCATGTCA -297 
- - 





CAGCCCCAGC AACCACACA~ GCCTGACAA CTTGCTGGGG TGGCCGCCTT GTGGTCTGAG -237 
430 440 450,3_ _ 460 2-- 470 1 480 




500 +$zEdJ 520 530 540 
ACAGACTGGA AGTGCTAA ACACCGCTTT ACAACGATGC AGGGGGCCCC -117 
550 560 570 580 590 600 
ATGTCACCCT CACCCATGGG AAGTTTGACT TGGTGGACTC AGCCAAGCCA CAGAGGTCTA - 57 
610 620 630 640 650 +l660 




Fig.3. Nucleotide sequence of the 5’ untranslated region of the human TRGV9 gene. Only direct repeats equal to or greater than 8 
nucleotides and less than 30 nucleotides distant are indicated by underlining arrows. Dashed arrows show inverted complementary se- 
quences. The boxed sequence is found to be identical, except for the absence of one nucleotide (T), to that in the promoter region of 
the TRDV2 (see fig.2). 
ventional TATA or CAAT [38] boxes could be 
found in either the TRGV9 or TRDV2 promoter 
regions. This is unlike most other eukaryotic pro- 
moters including promoters of human T-cell recep- 
tor /3 variable genes which do have these two se- 
quences approx. 30 and 80 bp upstream of the 
transcription start sites [38]. Moreover, the 
TRDV2 and TRGVB promoters do not possess the 
CCGCCC (or its inverted form GGGCGG) 
repeated sequences (‘GC’ box) which have been 
identified in promoters without typical TATA and 
CAAT boxes as, for example, promoters of 
‘house-keeping’ genes [40, 411 or of viral genes 
[42]. However, these regions are rich in short 8-10 
bp direct repeat sequences (underlining arrows in 
figs 2, 3). Two of them in tandem (repeats 1, 2) are 
188 
localized between two complementary and reverse 
sequences in the TRGV9 promoter region (dashed 
arrows in fig.3). Note that the decanucleotide se- 
quence of repeat 1 (TGTGGTCTGA) (fig.3) bears 
relaxed homology to an enhancer core sequence 
(5 ’ -TGTGG(AAA/TTA)G-3 ’ ) that has been pro- 
posed on the basis of DNA sequence comparisons 
and in vitro mutagenesis experiments (review [43]). 
Interestingly, despite the absence of homology 
between the promoter regions of TRDV2 and 
TRGV9, a characteristic decanucleotide 
AGGTGGT(T)GAG is found 36 and 157 bp 
upstream of the ATG codon of the TRDV2 and 
TRGVPgenes, respectively, with however an addi- 
tional nucleotide (T) in the V2 sequence. The 
TRDV2 sequence also possesses the octanucleotide 
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........................................ ..T * .. ............... 
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GAAAGCACAG*TGCCTGCAGA&GC A~GGTGATTTCAGGCTGCCCTGGCA 
M 
Fig.4. Nucleotide sequences of the 5’ untranslated region of the human Vy I (VI, V2, V3, V4, V8) and Vy II (V9) subgroup genes. 
Nucleotide + 1 denotes the A of the ATG encoding the initiation methionine codon (M). The Sac1 site is underlined in the TRGVI se- 
quence. The putative TATA and CACAT sequences are boxed in the TRGVI sequence. Deletions are shown by asterisks. Dots indicate 
identical nucleotides. Since the 5’ region of the Vy I subgroup genes and that of the V9 gene could not be aligned, these sequences are 
given in full. 
TCCTCAGT which was found 100 bp upstream of 
the ATG of the HD-Mar Va transcript [44], a Va 
gene without a TATA or CAAT box. It is of in- 
terest that this octanucleotide occupies the same 
position in the promoter region of TRDV2. The se- 
quencing of the promoter region of the TRGVl, 
V2, V3, V4 and Vg genes belonging to the Vy I 
subgroup was carried out in order to search for the 
characteristic features of the TRDV2 and TRGV9 
genes, i.e. the absence of the TATA and CAAT 
boxes and the presence of direct repeats and 
decanucleotide. In contrast to the TRGV9 gene, 
the promoter regions of the TRGV y I genes shown 
in fig.4 seem to have conventional, although poor- 
ly conserved, TATA and CAAT promoters. 
4. DISCUSSION 
In the CD3 + TcR y/6 + lymphocytes, produc- 
tive rearrangements involving the TRG 1 region and 
the Vy9 gene occur preferentially before rear- 
rangements involving the TRG2 region during the 
process of T lymphocyte differentation [32]. In the 
CD3 + TcR a/p+ lymphocytes, the TRGV 
subgroup I genes are preferentially rearranged to 
the TRG2 region, but are rarely transcribed 
[45-481. This observation suggests that the two 
TRG regions as well as the four TRGV gene 
subgroups are activated in a sequentially ordered 
fashion [32]. Thus, the TRGV9 gene which is 
transcribed in the majority of the CD3 + TcR 
189 
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y/6 + lymphocytes [3 1,321 might be subject to cell- 
specific transcriptional control early in differentia- 
tion. Analysis of the TRDV2 and TRGV9 gene 
structure is therefore a crucial first step toward stu- 
dying the mechanism which regulates their expres- 
sion. Two features that have been reported in the 
promoter region of the CD3 6 gene [49, 501 are 
observed at the 5 ’ -end of TRDV2 and TRGV9 (but 
not in the case of the V y subgroup I genes): lack 
of TATA and CAAT boxes and presence of short 
repeats in tandem. These repeats may play a role in 
the activation of this gene, like that of a TATA 
box, by defining start positions for the RNA 
polymerase. The structure of these different pro- 
moter regions may be used by activation 
mechanisms pecific of genes expressed uring ear- 
ly T-cell differentiation, like the CD3 6 gene and 
the TRGV9 and TRDV2 genes. Note that other 
genes which are also expressed early in T-cell dif- 
ferentation, the CD3 y [51] and E [52] genes, the 
CD2 gene [53] and the mouse Thy-l [54] lack 
TATA, CAAT and GC boxes. Finally, the 
presence of a characteristic decanucleotide in the 
promoter regions of the TRDV2 and TRGV9 genes 
may have some biological significance, since both 
TRDV2 and TRGV9 genes both appear to be ex- 
pressed early in T-cell differentiation [31, 321. 
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